Exclusive: TPG ropes in co-investors for drugmaker iNova’s buyout

 Exclusive: TPG ropes in co-investors for drugmaker iNova’s buyout
Private equity firm TPG has brought on board a few large co-investors to seal a multi-billion-dollar transaction to buy out iNova Pharmaceuticals, which has operations across Australasia, Asia and Africa and is currently owned by Carlyle and Pacific Equity Partners (PEP). The proposed deal would see Carlyle exiting and PEP […]
To read the rest of this article, you must be a subscriber. Click here to buy a subscription plan or Login here if you are already a subscriber.

Vivek Sinha

error: Content is protected !!
The Capital Quest